Home
»
SV Life Sciences
Skip to content
FinSMEs
REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS
Search for:
Facebook
Twitter
Linkedin
Navigation
Site navigation
USA
UK
Germany
Canada
China
Russia
India
France
Italy
NFT
Home
SV Life Sciences
SV Life Sciences
USA
SV Life Sciences Rebrands As SV Health Investors
UK
Pulmocide Raises $30M in Series B Financing
UK
Artios Pharma Raises $33.2M in Series A Funding
USA
Healthcare Company Aligned TeleHealth Raises $12M
USA
Digital Health Medtech Company Endotronix Raises $32m in Series C Funding
UK
USA
Life Sciences Venture Capital Firm SV Life Sciences Holds First Close of Fund at $273.5M
USA
SV Life Sciences Appoints Dr. Joshua Resnick as Partner
USA
Deciphera Pharmaceuticals Increases Size of Series B Round to over $90M
UK
Kesios Therapeutics Closes £19M Series A Financing
UK
$100M Dementia Discovery Fund Launches
USA
ReShape Medical Closes $38M Series D Funding Round
USA
Avitide Closes Series C Financing
UK
KalVista Pharmaceuticals Raises $33M in Series B Financing
USA
Autifony Therapeutics Raises £8M in Series A Funding
USA
EBR Systems Raises $20M in Funding
Posts navigation
←
Older posts
Sign-up now to the Daily Newsletter